Sparfloxacin
Sparfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections. It has a controversial safety profile.
Clinical data | |
---|---|
Pronunciation | spar FLOX a sin |
Trade names | Spacin, Zagam, others |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a600002 |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 92% |
Protein binding | 45% |
Metabolism | Hepatic glucuronidation Cytochrome P450 system not involved |
Elimination half-life | 16 to 30 hours |
Excretion | Fecal (50%) and renal (50%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.157.238 |
Chemical and physical data | |
Formula | C19H22F2N4O3 |
Molar mass | 392.407 g·mol−1 |
3D model (JSmol) | |
Melting point | 266 to 269 °C (511 to 516 °F) (dec.) |
| |
| |
(verify) |
It was patented in 1985 and approved for medical use in 1993. Zagam is no longer available in the United States.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.